MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Portola Pharmaceuticals Company Profile (NASDAQ:PTLA)

Consensus Ratings for Portola Pharmaceuticals (NASDAQ:PTLA) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $51.00 (11.23% upside)

Analysts' Ratings History for Portola Pharmaceuticals (NASDAQ:PTLA)
Show:
DateFirmActionRatingPrice TargetActions
6/23/2015Credit SuisseInitiated CoverageOutperform$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Credit SuisseBoost Price Target$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2013Cowen and CompanyLower Price TargetOutperform$47.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/16/2013Cowen and CompanyBoost Price TargetOutperform$45.37 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/3/2013 forward)